LIPID SUBSTITUTION OF MITOCHONDRIAL MONOAMINE-OXIDASE CAN LEAD TO THE ABOLITION OF CLORGYLINE SELECTIVE-INHIBITION WITHOUT ALTERATION IN THE A-B RATIO ASSESSED BY SUBSTRATE UTILIZATION

被引：28

|

作者：

HOUSLAY, MD

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1980年 / 29卷 / 23期

关键词：

D O I：

10.1016/0006-2952(80)90589-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：3211 / 3213

页数：3

相关论文

共 2 条

[1] INVESTIGATIONS OF THE MECHANISM OF SELECTIVE-INHIBITION OF TYPE-B MITOCHONDRIAL MONOAMINE-OXIDASE BY PHOSPHATIDYLSERINE
BUCKMAN, TD
EIDUSON, S
BOSCIA, R
[J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (23) : 3639 - 3647
[2] SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE TYPE-B BY MDL-72145 INCREASES THE CENTRAL EFFECTS OF L-DOPA WITHOUT MODIFYING ITS CARDIOVASCULAR EFFECTS
FOZARD, JR
PALFREYMAN, MG
ROBIN, M
ZREIKA, M
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (01) : 257 - 264